https://business-news.org/article/464401-exemption-of-certain-categories-of-biological-products-from-certain-reporting-requirements2026-10-17T03:26:33.890Z0.6https://business-news.org/article/464402-assessing-adhesion-with-transdermal-and-topical-delivery-systems-for-abbreviated-new-drug-2026-10-17T03:26:35.756Z0.6https://business-news.org/article/464403-assessing-the-irritation-and-sensitization-potential-of-transdermal-and-topical-delivery-s2026-10-17T03:26:35.136Z0.6https://business-news.org/article/464404-over-the-counter-monograph-order-requests-format-and-content-draft-guidance-for-industry-a2026-10-17T03:26:34.790Z0.6https://business-news.org/article/464405-food-and-drug-administration-data-and-technology-strategic-plan-request-for-information-an2026-10-17T03:26:34.792Z0.6https://business-news.org/article/464406-a-risk-based-approach-to-monitoring-of-clinical-investigations-questions-and-answers-guida2026-10-17T03:26:36.785Z0.6https://business-news.org/article/464407-agency-information-collection-activities-proposed-collection-comment-request-food-labeling2026-10-17T03:26:36.770Z0.6https://business-news.org/article/464408-olga-l-torres-final-debarment-order2026-10-17T03:26:32.630Z0.6https://business-news.org/article/464409-center-for-devices-and-radiological-health-radiation-sterilization-master-file-pilot-progr2026-10-17T03:26:17.993Z0.6https://business-news.org/article/464410-vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishmen2026-10-17T03:26:18.399Z0.6https://business-news.org/article/464411-agency-information-collection-activities-proposed-collection-comment-request-investigation2026-10-17T03:26:18.006Z0.6https://business-news.org/article/464412-agency-information-collection-activities-proposed-collection-comment-request-generic-drug-2026-10-17T03:26:17.864Z0.6https://business-news.org/article/464413-agency-information-collection-activities-proposed-collection-comment-request-medical-devic2026-10-17T03:26:26.650Z0.6https://business-news.org/article/464414-cellular-tissue-and-gene-therapies-advisory-committee-notice-of-meeting-establishment-of-a2026-10-17T03:26:26.673Z0.6https://business-news.org/article/464415-agency-information-collection-activities-proposed-collection-comment-request-focus-groups-2026-10-17T03:26:26.729Z0.6https://business-news.org/article/464416-agency-information-collection-activities-proposed-collection-comment-request-imports-and-e2026-10-17T03:26:32.587Z0.6https://business-news.org/article/464417-agency-information-collection-activities-proposed-collection-comment-request-generic-clear2026-10-17T03:26:27.001Z0.6https://business-news.org/article/464418-use-of-salt-substitutes-to-reduce-the-sodium-content-in-standardized-foods2026-10-17T03:26:26.483Z0.6https://business-news.org/article/464419-patient-focused-drug-development-incorporating-clinical-outcome-assessments-into-endpoints2026-10-17T03:26:32.619Z0.6https://business-news.org/article/464420-notification-of-a-permanent-discontinuance-or-interruption-in-manufacturing-under-section-2026-10-17T03:26:18.434Z0.6https://business-news.org/article/464421-list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-2026-10-17T03:26:18.604Z0.6https://business-news.org/article/464422-action-levels-for-lead-in-food-intended-for-babies-and-young-children-draft-guidance-for-i2026-10-17T03:26:18.005Z0.6https://business-news.org/article/464423-considerations-for-long-term-clinical-neurodevelopmental-safety-studies-in-neonatal-produc2026-10-17T03:26:18.133Z0.6https://business-news.org/article/464424-human-user-safety-in-new-and-abbreviated-new-animal-drug-applications-draft-guidance-for-i2026-10-17T03:26:32.525Z0.6https://business-news.org/article/464425-in-home-disposal-systems-for-opioid-analgesics-request-for-information2026-10-17T03:26:08.813Z0.6https://business-news.org/article/464426-marketing-submission-recommendations-for-a-predetermined-change-control-plan-for-artificia2026-10-17T03:26:08.569Z0.6https://business-news.org/article/464427-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T03:26:08.986Z0.6https://business-news.org/article/464428-research-involving-children-as-subjects-and-not-otherwise-approvable-by-an-institutional-r2026-10-17T03:26:08.974Z0.6https://business-news.org/article/464429-infectious-otitis-externa-drugs-for-topical-use-in-dogs-draft-guidance-for-industry-availa2026-10-17T03:26:08.608Z0.6https://business-news.org/article/464430-cybersecurity-in-medical-devices-refuse-to-accept-policy-for-cyber-devices-and-related-sys2026-10-17T03:26:21.997Z0.6https://business-news.org/article/464431-issuance-of-priority-review-voucher-rare-pediatric-disease-product2026-10-17T03:26:22.049Z0.6https://business-news.org/article/464432-identification-of-medicinal-products-implementation-and-use-guidance-for-industry-availabi2026-10-17T03:26:09.741Z0.6https://business-news.org/article/464433-determination-of-regulatory-review-period-for-purposes-of-patent-extension-m6-c-artificial2026-10-17T03:26:09.851Z0.6https://business-news.org/article/464434-filing-of-color-additive-petition-from-center-for-science-in-the-public-interest-et-al-req2026-10-17T03:26:09.539Z0.6https://business-news.org/article/464435-joint-meeting-of-the-psychopharmacologic-drugs-advisory-committee-and-the-peripheral-and-c2026-10-17T03:26:09.406Z0.6https://business-news.org/article/464436-glaxosmithkline-intellectual-property-development-ltd-england-announcement-of-the-revocati2026-10-17T03:26:09.440Z0.6https://business-news.org/article/464437-medical-devices-orthopedic-devices-classification-of-spinal-spheres-for-use-in-interverteb2026-10-17T03:26:09.238Z0.6https://business-news.org/article/464438-effective-date-of-requirement-for-premarket-approval-applications-for-spinal-spheres-for-u2026-10-17T03:26:10.789Z0.6https://business-news.org/article/464439-orthopedic-non-spinal-bone-plates-screws-and-washers-premarket-notification-510-k-submissi2026-10-17T03:26:10.972Z0.6https://business-news.org/article/464440-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T03:26:10.893Z0.6https://business-news.org/article/464441-yogurt-products-deviating-from-standard-of-identity-temporary-permit-for-market-testing2026-10-17T03:25:56.157Z0.6https://business-news.org/article/464442-soft-hydrophilic-daily-wear-contact-lenses-performance-criteria-for-safety-and-performance2026-10-17T03:25:56.320Z0.6https://business-news.org/article/464443-general-considerations-for-animal-studies-intended-to-evaluate-medical-devices-guidance-fo2026-10-17T03:25:56.160Z0.6https://business-news.org/article/464444-questions-and-answers-about-dietary-guidance-statements-in-food-labeling-draft-guidance-fo2026-10-17T03:25:57.187Z0.6https://business-news.org/article/464445-over-the-counter-monograph-drug-user-fee-rates-for-fiscal-year-20232026-10-17T03:25:56.950Z0.6https://business-news.org/article/464446-transition-plan-for-medical-devices-issued-emergency-use-authorizations-related-to-coronav2026-10-17T03:25:56.833Z0.6https://business-news.org/article/464447-transition-plan-for-medical-devices-that-fall-within-enforcement-policies-issued-during-th2026-10-17T03:25:56.617Z0.6https://business-news.org/article/464448-change-of-address-technical-amendment2026-10-17T03:25:56.497Z0.6https://business-news.org/article/464449-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T03:25:56.659Z0.6https://business-news.org/article/464450-clinical-trial-considerations-to-support-accelerated-approval-of-oncology-therapeutics-dra2026-10-17T03:25:56.295Z0.6https://business-news.org/article/464451-framework-for-the-use-of-digital-health-technologies-in-drug-and-biological-product-develo2026-10-17T03:25:57.224Z0.6https://business-news.org/article/464452-food-labeling-infant-formula-requirements-food-additives-and-generally-recognized-as-safe-2026-10-17T03:25:57.015Z0.6https://business-news.org/article/464453-changes-to-third-party-vendors-for-risk-evaluation-and-mitigation-strategies-establishment2026-10-17T03:26:21.942Z0.6https://business-news.org/article/464454-determination-of-regulatory-review-period-for-purposes-of-patent-extension-recell-autologo2026-10-17T03:26:11.224Z0.6https://business-news.org/article/464455-determination-of-regulatory-review-period-for-purposes-of-patent-extension-cintec-plus-cyt2026-10-17T03:26:11.436Z0.6https://business-news.org/article/464456-determination-of-regulatory-review-period-for-purposes-of-patent-extension-tegsedi2026-10-17T03:26:10.828Z0.6https://business-news.org/article/464457-determination-of-regulatory-review-period-for-purposes-of-patent-extension-galafold2026-10-17T03:26:09.549Z0.6https://business-news.org/article/464458-determination-of-regulatory-review-period-for-purposes-of-patent-extension-mulpleta2026-10-17T03:26:09.876Z0.6https://business-news.org/article/464459-agency-information-collection-activities-proposed-collection-comment-request-food-canning-2026-10-17T03:26:01.267Z0.6https://business-news.org/article/464460-determination-of-regulatory-review-period-for-purposes-of-patent-extension-esperoct2026-10-17T03:26:10.086Z0.6https://business-news.org/article/464461-medical-devices-technical-amendments2026-10-17T03:26:09.825Z0.6https://business-news.org/article/464462-determination-of-regulatory-review-period-for-purposes-of-patent-extension-ic-8-apthera-in2026-10-17T03:26:21.941Z0.6https://business-news.org/article/464463-determination-of-regulatory-review-period-for-purposes-of-patent-extension-jivi2026-10-17T03:26:10.331Z0.6https://business-news.org/article/464464-pharmacogenomic-data-submissions-draft-guidance-for-industry-availability2026-10-17T03:26:10.302Z0.6https://business-news.org/article/464465-new-animal-drugs-approval-of-new-animal-drug-applications-change-of-sponsor2026-10-17T03:26:08.154Z0.6https://business-news.org/article/464466-definition-of-the-term-tobacco-product-in-guidances-issued-under-the-federal-food-drug-and2026-10-17T03:26:08.403Z0.6https://business-news.org/article/464467-definition-of-the-term-tobacco-product-in-regulations-issued-under-the-federal-food-drug-a2026-10-17T03:26:08.037Z0.6https://business-news.org/article/464468-development-of-local-anesthetic-drug-products-with-prolonged-duration-of-effect-draft-guid2026-10-17T03:26:10.085Z0.6https://business-news.org/article/464469-issuance-of-priority-review-voucher-rare-pediatric-disease-product2026-10-17T03:26:10.249Z0.6https://business-news.org/article/464470-electronic-systems-electronic-records-and-electronic-signatures-in-clinical-investigations2026-10-17T03:26:01.808Z0.6https://business-news.org/article/464471-listing-of-color-additives-exempt-from-certification-spirulina-extract-confirmation-of-eff2026-10-17T03:26:08.459Z0.6https://business-news.org/article/464472-fresenius-kabi-usa-llc-et-al-withdrawal-of-approval-of-six-abbreviated-new-drug-applicatio2026-10-17T03:26:08.385Z0.6https://business-news.org/article/464473-definitions-of-suspect-product-and-illegitimate-product-for-verification-obligations-under2026-10-17T03:25:44.832Z0.6https://business-news.org/article/464474-request-for-nominations-from-industry-organizations-interested-in-participating-in-the-sel2026-10-17T03:25:44.553Z0.6https://business-news.org/article/464475-issuance-of-priority-review-voucher-rare-pediatric-disease-product2026-10-17T03:25:44.681Z0.6https://business-news.org/article/464476-the-use-of-published-literature-in-support-of-new-animal-drug-approvals-guidance-for-indus2026-10-17T03:25:44.613Z0.6https://business-news.org/article/464477-guidance-documents-related-to-coronavirus-disease-2019-covid-192026-10-17T03:25:45.301Z0.6https://business-news.org/article/464478-authorization-of-emergency-use-of-a-drug-product-during-the-covid-19-pandemic-availability2026-10-17T03:25:45.284Z0.6https://business-news.org/article/464479-evaluation-of-gastric-ph-dependent-drug-interactions-with-acid-reducing-agents-study-desig2026-10-17T03:25:44.947Z0.6https://business-news.org/article/464480-revocation-of-three-authorizations-of-emergency-use-of-in-vitro-diagnostic-devices-for-det2026-10-17T03:25:45.157Z0.6https://business-news.org/article/464481-agency-information-collection-activities-proposed-collection-comment-request-custom-device2026-10-17T03:25:44.915Z0.6https://business-news.org/article/464482-authorization-of-emergency-use-of-an-in-vitro-diagnostic-device-in-response-to-an-outbreak2026-10-17T03:25:59.144Z0.6https://business-news.org/article/464483-proposed-requirements-for-tobacco-products-manufacturing-practice-tobacco-products-scienti2026-10-17T03:25:48.164Z0.6https://business-news.org/article/464484-proposed-requirements-for-tobacco-product-manufacturing-practice-public-hearing-request-fo2026-10-17T03:25:53.060Z0.6https://business-news.org/article/464485-requirements-for-tobacco-product-manufacturing-practice2026-10-17T03:25:48.165Z0.6https://business-news.org/article/464486-mammography-quality-standards-act2026-10-17T03:25:48.017Z0.6https://business-news.org/article/464487-new-animal-drugs-approval-of-new-animal-drug-applications-withdrawal-of-approval-of-new-an2026-10-17T03:25:48.153Z0.6https://business-news.org/article/464488-revocation-of-two-authorizations-of-emergency-use-of-in-vitro-diagnostic-devices-for-detec2026-10-17T03:25:53.078Z0.6https://business-news.org/article/464489-fosun-pharma-usa-inc-withdrawal-of-approval-of-abbreviated-new-drug-application-for-pemoli2026-10-17T03:25:59.246Z0.6https://business-news.org/article/464490-evaluating-the-safety-of-antimicrobial-new-animal-drugs-with-regard-to-their-microbiologic2026-10-17T03:25:53.041Z0.6https://business-news.org/article/464491-determination-that-lithium-citrate-oral-solution-8-milliequivalents-5-milliliters-was-not-2026-10-17T03:25:53.061Z0.6https://business-news.org/article/464492-joint-meeting-of-the-nonprescription-drugs-advisory-committee-and-the-anesthetic-and-analg2026-10-17T03:25:51.495Z0.6https://business-news.org/article/464493-blood-products-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-reque2026-10-17T03:25:51.435Z0.6https://business-news.org/article/464494-potency-assay-considerations-for-monoclonal-antibodies-and-other-therapeutic-proteins-targ2026-10-17T03:25:51.223Z0.6https://business-news.org/article/464495-change-of-address-technical-amendment2026-10-17T03:25:51.012Z0.6https://business-news.org/article/464496-statement-of-organization-functions-and-delegations-of-authority2026-10-17T03:25:53.378Z0.6https://business-news.org/article/464497-q13-continuous-manufacturing-of-drug-substances-and-drug-products-international-council-fo2026-10-17T03:25:46.321Z0.6https://business-news.org/article/464498-discussion-paper-artificial-intelligence-in-drug-manufacturing-notice-request-for-informat2026-10-17T03:25:45.621Z0.6https://business-news.org/article/464499-determination-of-regulatory-review-period-for-purposes-of-patent-extension-vyzulta2026-10-17T03:25:45.817Z0.6https://business-news.org/article/464500-determination-of-regulatory-review-period-for-purposes-of-patent-extension-verzenio2026-10-17T03:25:45.860Z0.6https://business-news.org/article/464501-mylan-pharmaceuticals-inc-et-al-withdrawal-of-approval-of-11-abbreviated-new-drug-applicat2026-10-17T03:25:45.711Z0.6https://business-news.org/article/464502-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T03:25:29.928Z0.6https://business-news.org/article/464503-request-for-nominations-for-individuals-and-consumer-organizations-for-advisory-committees2026-10-17T03:25:29.780Z0.6https://business-news.org/article/464504-request-for-nominations-for-voting-members-for-the-patient-engagement-advisory-committee2026-10-17T03:25:29.733Z0.6https://business-news.org/article/464505-food-standards-general-principles-and-food-standards-modernization-withdrawal-of-proposed-2026-10-17T03:25:29.842Z0.6https://business-news.org/article/464506-richard-m-fleming-denial-of-hearing-on-application-for-termination-of-debarment2026-10-17T03:25:30.173Z0.6https://business-news.org/article/464507-agency-information-collection-activities-proposed-collection-comment-request-prior-notice-2026-10-17T03:25:30.818Z0.6https://business-news.org/article/464508-wojciech-lesniak-final-debarment-order2026-10-17T03:25:30.611Z0.6https://business-news.org/article/464509-innophos-inc-filing-of-color-additive-petition2026-10-17T03:25:30.675Z0.6https://business-news.org/article/464510-neovascular-age-related-macular-degeneration-developing-drugs-for-treatment-draft-guidance2026-10-17T03:25:30.616Z0.6https://business-news.org/article/464511-determination-that-chantix-varenicline-tartrate-tablets-0-5-milligram-and-1-milligram-has-2026-10-17T03:25:30.233Z0.6https://business-news.org/article/464512-timothy-baxter-denial-of-hearing-final-debarment-order2026-10-17T03:25:30.385Z0.6https://business-news.org/article/464513-shaun-thaxter-denial-of-hearing-final-debarment-order2026-10-17T03:25:30.233Z0.6https://business-news.org/article/464514-patient-focused-drug-development-for-long-covid-public-meeting-request-for-comments2026-10-17T03:25:59.277Z0.6https://business-news.org/article/464515-labeling-of-plant-based-milk-alternatives-and-voluntary-nutrient-statements-draft-guidance2026-10-17T03:25:46.296Z0.6https://business-news.org/article/464516-determination-that-asacol-hd-mesalamine-delayed-release-tablet-800-milligrams-was-not-with2026-10-17T03:25:59.248Z0.6https://business-news.org/article/464517-agency-information-collection-activities-proposed-collection-comment-request-premarket-not2026-10-17T03:25:47.281Z0.6https://business-news.org/article/464518-product-specific-guidance-meetings-between-the-food-and-drug-administration-and-abbreviate2026-10-17T03:25:35.332Z0.6https://business-news.org/article/464519-determination-that-topamax-topiramate-sprinkle-capsules-50-milligrams-was-not-withdrawn-fr2026-10-17T03:25:35.422Z0.6https://business-news.org/article/464520-agency-information-collection-activities-proposed-collection-comment-request-current-good-2026-10-17T03:25:35.293Z0.6https://business-news.org/article/464521-compliance-policy-guide-sec-397-100-accuracy-requirements-for-indication-of-temporal-maxim2026-10-17T03:25:35.185Z0.6https://business-news.org/article/464522-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T03:25:35.367Z0.6https://business-news.org/article/464523-filing-of-color-additive-petition-from-center-for-science-in-the-public-interest-et-al-req2026-10-17T03:25:47.404Z0.6https://business-news.org/article/464524-determination-that-miacalcin-calcitonin-salmon-injection-100-usp-units-milliliter-ml-was-n2026-10-17T03:25:47.321Z0.6https://business-news.org/article/464525-product-specific-guidances-draft-and-revised-draft-guidances-for-industry-reopening-of-the2026-10-17T03:25:37.119Z0.6https://business-news.org/article/464526-determination-that-dihydroergotamine-mesylate-45-injection-usp-1-milligram-milliliter-was-2026-10-17T03:25:36.953Z0.6https://business-news.org/article/464527-international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-n2026-10-17T03:25:36.581Z0.6https://business-news.org/article/464528-termination-of-authorization-of-emergency-use-of-an-in-vitro-diagnostic-for-detection-of-e2026-10-17T03:25:36.784Z0.6https://business-news.org/article/464529-electronic-submission-of-adverse-event-reports-to-the-food-and-drug-administration-adverse2026-10-17T03:25:36.847Z0.6https://business-news.org/article/464530-miles-laboratories-inc-withdrawal-of-approval-of-an-abbreviated-new-drug-application-for-a2026-10-17T03:25:36.668Z0.6https://business-news.org/article/464531-compounding-certain-ibuprofen-oral-suspension-products-under-section-503b-of-the-federal-f2026-10-17T03:25:15.781Z0.6https://business-news.org/article/464532-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T03:25:15.848Z0.6https://business-news.org/article/464533-determination-of-regulatory-review-period-for-purposes-of-patent-extension-aliqopa2026-10-17T03:25:16.067Z0.6https://business-news.org/article/464534-determination-that-aristospan-triamcinolone-hexacetonide-injectable-suspension-20-milligra2026-10-17T03:25:16.306Z0.6https://business-news.org/article/464535-considerations-for-long-term-clinical-neurodevelopmental-safety-studies-in-neonatal-produc2026-10-17T03:25:16.346Z0.6https://business-news.org/article/464536-agency-information-collection-activities-proposed-collection-comment-request-food-and-drug2026-10-17T03:25:15.934Z0.6https://business-news.org/article/464537-protein-efficiency-ratio-rat-bioassay-studies-to-demonstrate-that-a-new-infant-formula-sup2026-10-17T03:25:16.650Z0.6https://business-news.org/article/464538-emergent-biosolutions-inc-withdrawal-of-approval-of-a-supplemental-new-drug-application-fo2026-10-17T03:25:16.937Z0.6https://business-news.org/article/464539-temporary-policy-on-repackaging-or-combining-propofol-drug-products-during-the-covid-19-pu2026-10-17T03:25:16.336Z0.6https://business-news.org/article/464540-determination-of-regulatory-review-period-for-purposes-of-patent-extension-xospata2026-10-17T03:25:23.360Z0.6https://business-news.org/article/464541-determination-of-regulatory-review-period-for-purposes-of-patent-extension-erleada2026-10-17T03:25:23.300Z0.6https://business-news.org/article/464542-vaccines-and-related-biological-products-advisory-committee-notice-of-meeting-establishmen2026-10-17T03:25:23.540Z0.6https://business-news.org/article/464543-determination-of-regulatory-review-period-for-purposes-of-patent-extension-skyrizi2026-10-17T03:25:47.250Z0.6https://business-news.org/article/464544-determination-of-regulatory-review-period-for-purposes-of-patent-extension-remede-system2026-10-17T03:25:23.677Z0.6https://business-news.org/article/464545-determination-of-regulatory-review-period-for-purposes-of-patent-extension-lokelma2026-10-17T03:25:23.762Z0.6https://business-news.org/article/464546-hassan-tahsildar-denial-of-hearing-final-debarment-order2026-10-17T03:25:35.779Z0.6https://business-news.org/article/464547-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T03:25:13.317Z0.6https://business-news.org/article/464548-agency-information-collection-activities-proposed-collection-comment-request-administrativ2026-10-17T03:25:13.231Z0.6https://business-news.org/article/464549-advisory-committee-cellular-tissue-and-gene-therapies-advisory-committee-renewal2026-10-17T03:25:13.238Z0.6https://business-news.org/article/464550-determination-of-regulatory-review-period-for-purposes-of-patent-extension-yupelri2026-10-17T03:25:13.154Z0.6https://business-news.org/article/464551-determination-of-regulatory-review-period-for-purposes-of-patent-extension-doptelet2026-10-17T03:25:33.962Z0.6https://business-news.org/article/464552-understanding-priorities-for-the-development-of-digital-health-technologies-to-support-cli2026-10-17T03:25:33.731Z0.6https://business-news.org/article/464553-fiscal-year-2023-generic-drug-science-and-research-initiatives-workshop-public-workshop-re2026-10-17T03:25:33.737Z0.6https://business-news.org/article/464554-determination-of-regulatory-review-period-for-purposes-of-patent-extension-xiidra2026-10-17T03:25:13.480Z0.6https://business-news.org/article/464555-micro-tracers-inc-filing-of-food-additive-petition2026-10-17T03:25:13.600Z0.6https://business-news.org/article/464556-determination-that-triamcinolone-acetonide-triamcinolone-acetonide-topical-cream-0-025-and2026-10-17T03:25:13.174Z0.6https://business-news.org/article/464557-determination-of-regulatory-review-period-for-purposes-of-patent-extension-olumiant2026-10-17T03:25:13.236Z0.6https://business-news.org/article/464558-agency-information-collection-activities-proposed-collection-comment-request-potential-tob2026-10-17T03:25:12.785Z0.6https://business-news.org/article/464559-sami-anwar-denial-of-hearing-final-debarment-order2026-10-17T03:25:12.741Z0.6https://business-news.org/article/464560-report-on-the-performance-of-drug-and-biologics-firms-in-conducting-postmarketing-requirem2026-10-17T03:25:17.116Z0.6https://business-news.org/article/464561-allergan-sales-llc-et-al-withdrawal-of-approval-of-10-abbreviated-new-drug-applications-co2026-10-17T03:24:57.969Z0.6https://business-news.org/article/464562-medical-devices-hematology-and-pathology-devices-classification-of-the-software-algorithm-2026-10-17T03:24:57.948Z0.6https://business-news.org/article/464563-requirements-for-additional-traceability-records-for-certain-foods2026-10-17T03:24:58.929Z0.6https://business-news.org/article/464564-m13a-bioequivalence-for-immediate-release-solid-oral-dosage-forms-international-council-fo2026-10-17T03:24:58.861Z0.6https://business-news.org/article/464565-early-lyme-disease-as-manifested-by-erythema-migrans-developing-drugs-for-treatment-draft-2026-10-17T03:24:58.712Z0.6https://business-news.org/article/464566-determination-that-lotensin-benazepril-hydrochloride-tablets-5-milligrams-were-not-withdra2026-10-17T03:24:58.750Z0.6https://business-news.org/article/464567-science-advisory-board-to-the-national-center-for-toxicological-research-advisory-committe2026-10-17T03:24:58.554Z0.6https://business-news.org/article/464568-considerations-for-the-design-and-conduct-of-externally-controlled-trials-for-drug-and-bio2026-10-17T03:24:58.378Z0.6https://business-news.org/article/464569-revocation-of-four-authorizations-of-emergency-use-of-in-vitro-diagnostic-devices-for-dete2026-10-17T03:24:58.329Z0.6https://business-news.org/article/464570-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T03:24:57.892Z0.6https://business-news.org/article/464571-agency-information-collection-activities-proposed-collection-comment-request-submission-of2026-10-17T03:24:57.906Z0.6https://business-news.org/article/464572-authorization-of-emergency-use-of-two-in-vitro-diagnostic-devices-in-response-to-an-outbre2026-10-17T03:25:17.404Z0.6https://business-news.org/article/464573-agency-information-collection-activities-submission-for-office-of-management-and-budget-re2026-10-17T03:25:17.151Z0.6https://business-news.org/article/464574-medical-devices-cardiovascular-devices-classification-of-the-software-for-optical-camera-b2026-10-17T03:25:17.079Z0.6https://business-news.org/article/464575-surveying-leveling-and-alignment-laser-products-guidance-for-industry-and-food-and-drug-ad2026-10-17T03:25:13.852Z0.6https://business-news.org/article/464576-agency-information-collection-activities-proposed-collection-comment-request-current-good-2026-10-17T03:25:09.218Z0.6https://business-news.org/article/464577-agency-information-collection-activities-proposed-collection-comment-request-premarket-app2026-10-17T03:25:00.560Z0.6https://business-news.org/article/464578-recommendations-for-evaluating-donor-eligibility-using-individual-risk-based-questions-to-2026-10-17T03:25:12.659Z0.6https://business-news.org/article/464579-acromegaly-developing-drugs-for-treatment-draft-guidance-for-industry-availability2026-10-17T03:25:12.234Z0.6https://business-news.org/article/464580-practices-to-prevent-unsafe-contamination-of-animal-feed-from-drug-carryover-guidance-for-2026-10-17T03:25:12.019Z0.6https://business-news.org/article/464581-joint-meeting-of-the-nonprescription-drugs-advisory-committee-and-the-anesthetic-and-analg2026-10-17T03:25:12.002Z0.6https://business-news.org/article/464582-statement-of-organization-functions-and-delegations-of-authority2026-10-17T03:25:01.507Z0.6https://business-news.org/article/464583-statement-of-organization-functions-and-delegations-of-authority2026-10-17T03:25:10.443Z0.6https://business-news.org/article/464584-agency-information-collection-activities-proposed-collection-comment-request-quantitative-2026-10-17T03:25:10.473Z0.6https://business-news.org/article/464585-compounding-certain-ibuprofen-oral-suspension-products-under-section-503b-of-the-federal-f2026-10-17T03:24:58.376Z0.6https://business-news.org/article/464586-mark-moffett-denial-of-hearing-final-debarment-order2026-10-17T03:24:58.241Z0.6https://business-news.org/article/464587-poornanand-palaparty-denial-of-hearing-final-debarment-order2026-10-17T03:25:01.898Z0.6https://business-news.org/article/464588-action-levels-for-lead-in-food-intended-for-babies-and-young-children-draft-guidance-for-i2026-10-17T03:25:01.795Z0.6https://business-news.org/article/464589-color-additive-certification-increase-in-fees-for-certification-services-reopening-of-the-2026-10-17T03:24:58.691Z0.6https://business-news.org/article/464590-cannabis-and-cannabis-derived-compounds-quality-considerations-for-clinical-research-guida2026-10-17T03:24:58.846Z0.6https://business-news.org/article/464591-determination-of-regulatory-review-period-for-purposes-of-patent-extension-byfavo2026-10-17T03:24:51.152Z0.6https://business-news.org/article/464592-advisory-committee-technical-electronic-product-radiation-safety-standards-committee-renew2026-10-17T03:24:50.970Z0.6https://business-news.org/article/464593-listing-of-color-additives-exempt-from-certification-calcium-carbonate-confirmation-of-eff2026-10-17T03:24:50.946Z0.6https://business-news.org/article/464594-clarification-of-orphan-drug-exclusivity-following-catalyst-pharms-inc-v-becerra-notificat2026-10-17T03:24:50.882Z0.6https://business-news.org/article/464595-medical-devices-ophthalmic-devices-classification-of-the-intense-pulsed-light-device-for-m2026-10-17T03:25:14.323Z0.6https://business-news.org/article/464596-medical-devices-gastroenterology-urology-devices-classification-of-the-computerized-behavi2026-10-17T03:25:14.143Z0.6https://business-news.org/article/464597-effectiveness-of-anthelmintics-specific-recommendations-for-products-proposed-for-the-prev2026-10-17T03:24:51.541Z0.6https://business-news.org/article/464598-mpox-development-of-drugs-and-biological-products-draft-guidance-for-industry-availability2026-10-17T03:24:51.171Z0.6https://business-news.org/article/464599-mark-godding-final-debarment-order2026-10-17T03:24:39.636Z0.6https://business-news.org/article/464600-linda-godding-final-debarment-order2026-10-17T03:24:39.504Z0.6